Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
AIDS Research and Human Retroviruses|January 1, 1994
Interest in HIV vaccines among injection drug users in Baltimore, MarylandD Vlahov, J Astemborski, L Solomon, et al.Journal of Urban Health : Bulletin of the New York Academy of Medicine|December 28, 1999
Evaluating supervised HAART in late-stage HIV among drug users: a preliminary reportB Greenberg, A Berkman, R Thomas, et al.AIDS Care|May 17, 2007
Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug usersS H Mehta, G Lucas, J Astemborski, et al.AIDS (London, England)|September 4, 1998
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex diseaseT R Sterling, R D Moore, N M Graham, et al.American Journal of Epidemiology|April 15, 1993
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug usersL Solomon, J Astemborski, D Warren, et al.JAMA|March 25, 1992
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infectionJ B Margolick, A Muñoz, D Vlahov, et al.The New England Journal of Medicine|March 10, 2001
Initial plasma HIV-1 RNA levels and progression to AIDS in women and menT R Sterling, D Vlahov, J Astemborski, et al.Journal of Clinical Microbiology|February 3, 2000
Screening for hepatitis C virus in human immunodeficiency virus-infected individualsC L Thio, K R Nolt, J Astemborski, et al.The Journal of Infectious Diseases|August 7, 1999
Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconvertersT R Sterling, C M Lyles, D Vlahov, et al.The Journal of Infectious Diseases|August 1, 1993
Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug usersH Farzadegan, D Vlahov, L Solomon, et al.Pageof 5